We’re one of the first firms to deliver coverage of foreign growth companies tailored specifically to U.S. investors.

Research Reports

Our research reports are available to our clients. If you are an existing client and already have a username and password, please login. If you are an existing client and want to register for access to the site, please use the registration form below.

If you are a potential client and are interested in finding out how Chardan can help you, please contact Shai Gerson at 646-465-9008.

Datesort icon Company Title Sector Symbol Rating Analyst Document
April 21, 2014 22nd Century Group, Inc. XXII files mixed-use shelf, and provides update. IP Monetization XXII Buy JAMES McILREE, CFA Log In or Register
April 17, 2014 Himax Technologies Announces Inline Q1:14 Revs; Q2:14 Guidance Could Disappoint; Lowering PT to $9 Technology HIMX Neutral Jay Srivatsa Log In or Register
April 16, 2014 Himax Technologies Announces Inline Q1:14 Revs; Q2:14 Guidance Could Disappoint; Lowering PT to $9 Technology HIMX Neutral Jay Srivatsa Log In or Register
April 16, 2014 Chardan Global Insights - Apr 16 2014 HIMX Chardan Capital Markets Research Log In or Register
April 15, 2014 Neostem Inc. NBS Acquiring California Stem Cell Inc. Reiterate Buy. Biotechnology & Pharmaceuticals NBS Buy Ling Wang Log In or Register
April 15, 2014 Chardan Global Insights - Apr 15 2014 NBS Chardan Capital Markets Research Log In or Register
April 10, 2014 DigitalGlobe Inc. EnhancedView GEOINT Delivery IP Monetization DGI Buy JAMES McILREE, CFA Log In or Register
April 10, 2014 Chardan Global Insights - Apr 10 2014 DGI ORBC Chardan Capital Markets Research Log In or Register
April 10, 2014 22nd Century Group, Inc. FDA Reference Cigarette Award to U of Kentucky IP Monetization XXII Buy JAMES McILREE, CFA Log In or Register
April 9, 2014 DigitalGlobe Inc. WorldView-3 Environmental Testing Complete. UrtheCast first images available. IP Monetization DGI Buy JAMES McILREE, CFA Log In or Register

Coverage Universe

April 1, 2014

To learn more about our Research Group, please contact Jay Srivatsa at 646-465-9065